Pages that link to "Q34686801"

The following pages link to A soluble form of CD4 (T4) protein inhibits AIDS virus infection (Q34686801):

Displaying 50 items.

• Energetics of the HIV gp120-CD4 binding reaction (Q22254716) ‎ (← links)
• Cloning of ACP33 as a novel intracellular ligand of CD4 (Q24290610) ‎ (← links)
• Molecular biology and function of CD4 and CD8 (Q24299317) ‎ (← links)
• Identification of amino acid residues critical for the Src-homology 2 domain-dependent docking of Stat2 to the interferon alpha receptor (Q24317719) ‎ (← links)
• Dimeric association and segmental variability in the structure of human CD4 (Q24324340) ‎ (← links)
• Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway (Q24619935) ‎ (← links)
• Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments (Q24646897) ‎ (← links)
• Neutralization of poliovirus by cell receptors expressed in insect cells (Q24655726) ‎ (← links)
• The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation (Q24676509) ‎ (← links)
• The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle (Q24685965) ‎ (← links)
• Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6 (Q27469855) ‎ (← links)
• Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 (Q27658449) ‎ (← links)
• Deciphering the mystery of hepatitis B virus receptors: A historical perspective. (Q27692529) ‎ (← links)
• Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding (Q27734294) ‎ (← links)
• Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure (Q27860618) ‎ (← links)
• Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution (Q28287140) ‎ (← links)
• Interaction of CD4 with HLA class II antigens and HIV gp120 (Q28290484) ‎ (← links)
• In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors (Q28323307) ‎ (← links)
• CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro (Q28343161) ‎ (← links)
• CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle (Q28359667) ‎ (← links)
• Inhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphate (Q28367647) ‎ (← links)
• Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction (Q28609565) ‎ (← links)
• Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains (Q30195771) ‎ (← links)
• Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States (Q30401836) ‎ (← links)
• CD4 and its role in infection of rabbit cell lines by human immunodeficiency virus type 1 (Q31076336) ‎ (← links)
• Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor (Q33223969) ‎ (← links)
• Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. (Q33434319) ‎ (← links)
• Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants (Q33490833) ‎ (← links)
• Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule (Q33584112) ‎ (← links)
• Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells (Q33637970) ‎ (← links)
• Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain (Q33641132) ‎ (← links)
• Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor (Q33644217) ‎ (← links)
• Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. (Q33656997) ‎ (← links)
• Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis (Q33682284) ‎ (← links)
• Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals (Q33754489) ‎ (← links)
• High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates (Q33760671) ‎ (← links)
• Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4. (Q33780620) ‎ (← links)
• CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway (Q33782459) ‎ (← links)
• Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis (Q33795266) ‎ (← links)
• Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120 (Q33797964) ‎ (← links)
• Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping (Q33804059) ‎ (← links)
• Soluble receptor-induced retroviral infection of receptor-deficient cells (Q33807796) ‎ (← links)
• Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor (Q33835427) ‎ (← links)
• Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys (Q33839485) ‎ (← links)
• Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants (Q33850415) ‎ (← links)
• Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor (Q33854208) ‎ (← links)
• Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. (Q33854440) ‎ (← links)
• Quantifying the infectivity of human immunodeficiency virus (Q33863493) ‎ (← links)
• Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events (Q33936268) ‎ (← links)
• Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens (Q33946209) ‎ (← links)